Elekta AB Stock
Stocks
EKTA B
SE0000163628
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Cboe Europe
01:14:54 09/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 49.89 SEK | -2.56% |
|
-5.76% | -12.07% |
| 08:16pm | Aggregated short positions on the Stockholm Stock Exchange as of September 8 | FW |
| 06:22pm | UBS reiterates sell on Elekta, sees continued risks | FW |
| Market Cap | 20.33B 2.12B 1.82B 1.71B 1.57B 2.93B 200B 2.94B 7.86B 103B 7.96B 7.79B 327B | P/E 2027 * |
12.9x | P/E 2028 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 23.68B 2.47B 2.12B 2B 1.82B 3.41B 234B 3.42B 9.15B 120B 9.27B 9.07B 381B | EV / Sales 2027 * |
1.37x | EV / Sales 2028 * | 1.28x |
| Free-Float |
94.03% | Yield 2027 * |
4.82% | Yield 2028 * | 5.41% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| EKTA B | Delayed | |
CBOE
| EKTABs | Real-time | |
|
OTC Markets
| EKTAF | Delayed | |
|
London S.E.
| 0O5H | Delayed | |
|
Tradegate
| EJXB | Real-time | |
|
Borsa Italiana
| 1EKTA | End-of-day quote | |
|
Boerse Muenchen
| EJXB | Real-time | |
|
Deutsche Boerse AG
| EJXB | Delayed | |
|
CBOE
| 0O5H | Real-time | |
|
Börse Stuttgart
| EJXB | Delayed |
Last Transcript : Elekta AB
| 1 day | -2.44% | ||
| 1 week | -5.76% | ||
| Current month | -8.10% | ||
| 1 month | -3.67% | ||
| 3 months | -8.10% | ||
| 6 months | -16.13% | ||
| Current year | -12.07% |
| 1 week | 49.7 |  | 53.75 |
| 1 month | 49.7 | | 56.4 |
| Current year | 45.7 | | 66.7 |
| 1 year | 41.86 | | 66.7 |
| 3 years | 40.64 | | 90 |
| 5 years | 40.64 | | 117.45 |
| 10 years | 40.64 | | 145.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/09/2025 | |
Klara Eiritz
DFI | Director of Finance/CFO | - | 01/03/2026 |
Martin Svensson
IRC | Investor Relations Contact | - | 01/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 30/06/2010 | |
Wolfgang Reim
BRD | Director/Board Member | 70 | 15/09/2011 |
Laurent Leksell
CHM | Chairman | 74 | 03/09/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/7/26 | Buy | Director | 10,000 | 0.0027% | ||
| 29/5/26 | Buy | Director | 4,000 | 0.0011% | ||
| 28/5/26 | Buy | Director | 3,100 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.56% | -5.76% | +10.01% | -32.62% | 2.12B | |
| -1.80% | +0.66% | +23.96% | +16.63% | 227B | |
| -0.82% | -0.10% | +4.08% | -16.76% | 146B | |
| -4.06% | -5.03% | -25.39% | +17.59% | 130B | |
| -2.95% | -5.19% | -57.85% | -15.38% | 69.27B | |
| -2.93% | -4.46% | +8.08% | +17.04% | 51.82B | |
| +0.89% | -0.99% | -18.15% | -12.89% | 49.99B | |
| -2.59% | -2.04% | +14.63% | +28.84% | 42.53B | |
| -1.52% | -0.51% | +30.51% | +53.19% | 40.22B | |
| -1.89% | +3.24% | +117.80% | +35.03% | 32.95B | |
| Average | -2.05% | -1.41% | +10.77% | +9.07% | 79.14B | |
| Weighted average by Cap. | -2.08% | -1.42% | +5.05% | +9.14% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 17.34B 1.81B 1.56B 1.46B 1.34B 2.5B 171B 2.51B 6.7B 87.58B 6.79B 6.64B 279B | 18.1B 1.89B 1.62B 1.53B 1.39B 2.61B 178B 2.61B 7B 91.39B 7.09B 6.93B 291B |
| Net income | 1.52B 159M 136M 128M 117M 219M 15.01B 220M 588M 7.68B 596M 583M 24.48B | 1.65B 172M 148M 139M 127M 237M 16.26B 238M 637M 8.33B 646M 631M 26.52B |
| Net Debt | 3.35B 350M 301M 283M 258M 483M 33.06B 484M 1.3B 16.93B 1.31B 1.28B 53.93B | 2.83B 295M 254M 239M 218M 407M 27.9B 409M 1.09B 14.29B 1.11B 1.08B 45.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | SEK 49.86 | -2.62% | 1,066,949 |
| 07/09/26 | SEK 51.20 | -2.10% | 1,310,185 |
| 04/09/26 | SEK 52.30 | -1.32% | 739,811 |
| 03/09/26 | SEK 53.00 | +0.57% | 991,230 |
| 02/09/26 | SEK 52.70 | -0.47% | 1,252,183 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EKTA B Stock
Select your edition
All financial news and data tailored to specific country editions
